The shares advanced as much as 23 percent, trading up 13 percent at 3:27 p.m. in Moscow, the most on an intraday level since July 4. The amount of shares trading was equivalent to 5.5 times the three-month average. Veropharm gained 15 percent to 830 rubles.
Moscow-based 36.6 agreed to sell a 52 percent stake in Veropharm for 5 billion rubles ($151 million) to billionaire Roman Avdeev’s GardenHills, according to a website statement today. 36.6’s debt stood at 8.3 billion rubles at the end of last year, while Veropharm’s debt equaled 1.5 billion rubles.
“The price is really good, higher than expected,” Marat Ibragimov, an analyst at Uralsib Capital, said by phone from Moscow. “36.6 has an enormous debt load, which curbed their operating profits. Now they’ll be able to cut their leverage.”
Veropharm’s total market capitalization was about 7.2 billion rubles at yesterday’s close, according to data compiled by Bloomberg.
To contact the reporter on this story: Ksenia Galouchko in Moscow at firstname.lastname@example.org
To contact the editor responsible for this story: Wojciech Moskwa at email@example.com